Clin2
NCT07508007Possibly a fitRecruiting

Study on improving Lp(a) testing in heart clinics

Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice

Part of Heart & circulation clinical trials.

This trial tests ways to help doctors check for high Lp(a), a risk factor for heart disease, in patients who need it. The study looks at whether special strategies increase testing rates in cardiology centers that currently test less than 15% of eligible patients.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
4,500 people
Ages
18 years and older
Study type
Observational

Who can take part

  • Your center must be a cardiology or similar clinic that already can test for Lp(a) and get it paid for.
  • Your clinic must currently test for Lp(a) in less than 15 out of every 100 eligible patients.
  • Your clinic must see enough eligible patients each year to meet the study's goals.
  • Your clinic must be willing to share data and follow the study plan.
  • You are a healthcare provider who manages heart disease risk and your center is joining the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06995183Recruiting
Heart CT scan for relatives with high or low Lp(a)

This study uses a heart CT scan to look for early signs of heart disease in first-degree relatives of people with high or low Lp(a). It aims to find hidden risks before symptoms start.

Amsterdam, North Holland
NCT07197242Not yet recruiting
How Lp(a) affects heart stent outcomes

This study looks at a type of fat in your blood called Lp(a) and whether it can help predict how well people do after getting a heart stent (PCI). If you have stable heart disease and are scheduled for a planned stent procedure, joining this study would involve a blood test before the procedure to check your Lp(a) levels.

NCT07729475Not yet recruiting· Phase 2
Testing an oral drug for high Lp(a) and heart risk

This trial tests whether a new once-daily pill called SAL0137 can safely lower Lp(a), a type of cholesterol that raises heart attack and stroke risk. It's for adults with high Lp(a) and other heart risk factors, like prior heart problems or diabetes.

Beijing, Beijing Municipality
NCT06858332Recruiting
Lp(a) cholesterol in adults with heart and blood vessel disease in Russia

This study looks at levels of a type of cholesterol called Lp(a) in people with certain heart and blood vessel diseases. The goal is to understand how common high Lp(a) is in Russian adults with these conditions.

Chelyabinsk
NCT07628270Recruiting
Heart Surgery Outcomes Study Using CT Scans and Blood Tests

This study follows patients who had heart bypass surgery guided by special CT scans and blood flow measurements. Researchers want to understand how well the surgery works and study a blood protein called Lp(a) that may affect heart health.

Milan, MI
NCT07324902Recruiting
How Lp(a) affects heart and blood vessel health

This study looks at how a fatty substance in your blood called lipoprotein(a), or Lp(a), might affect the stiffness of your arteries and how well your heart muscle works. It will help us understand if high Lp(a) is connected to early signs of heart disease.

Athens, Attica

Hear when a new Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.